Steinbach Alina, Riemer Angelika B
Immunotherapy & Immunoprevention, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Molecular Vaccine Design, German Center for Infection Research, Partner Site Heidelberg, Heidelberg, Germany.
Int J Cancer. 2018 Jan 15;142(2):224-229. doi: 10.1002/ijc.31027. Epub 2017 Sep 13.
Human papillomavirus (HPV) is the most frequently sexually transmitted agent in the world. It can cause cervical and other anogenital malignancies, and oropharyngeal cancer. HPV has the unique ability to persist in the host's epithelium for a long time-longer than most viruses do-which is necessary to complete its replication cycle. To this end, HPV has developed a variety of immune evasion mechanisms, which unfortunately also favor the progression of the disease from infection to chronic dysplasia and eventually to cancer. This article summarizes the current knowledge about HPV immune evasion strategies. A special emphasis lies in HPV-mediated changes of the antigen processing machinery, which is generating epitopes for T cells and contributes to the detectability of infected cells.
人乳头瘤病毒(HPV)是世界上最常见的性传播病原体。它可导致宫颈癌和其他肛门生殖器恶性肿瘤,以及口咽癌。HPV具有独特的能力,能够在宿主上皮中长期存活——比大多数病毒存活的时间更长——这是完成其复制周期所必需的。为此,HPV已经形成了多种免疫逃避机制,不幸的是,这些机制也有利于疾病从感染发展为慢性发育异常,并最终发展为癌症。本文总结了目前关于HPV免疫逃避策略的知识。特别强调的是HPV介导的抗原加工机制的变化,该机制产生T细胞表位并有助于检测受感染的细胞。